Skip to main content
SION
NASDAQ Life Sciences

RA Capital Files to Sell $21.8M of Sionna Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$7.41
Mkt Cap
$324.625M
52W Low
$4.01
52W High
$54.97
52W Position info
85% above low
Off High info
87% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

SION sits 85% above its 52-week low of $4.01.

Summary

RA Capital Healthcare Fund, a director and 10% stockholder, filed a Form 144 to sell 3,448,811 shares of Sionna Therapeutics worth approximately $21.8 million.


Key Events · Ownership and Investor Activity · SION

  • RA Capital Files $21.8M Sale

    RA Capital Healthcare Fund, L.P., a director and 10% stockholder, filed a Form 144 to sell 3,448,811 shares of common stock with an approximate market value of $21,834,318.

  • Sale Represents 7.6% of Outstanding Shares

    The 3,448,811 shares to be sold represent approximately 7.6% of the 45,212,399 shares outstanding, a substantial distribution by a major insider.

  • Follows Clinical Failure and Layoffs

    The filing comes three days after Sionna announced a 46% workforce reduction and strategic pivot following the failure of its lead CF drug, SION-719, in a Phase 2a trial.

  • Shares Acquired Across Three Tranches

    The shares were acquired in private transactions on 02/02/2022 (606,502 shares) and 03/04/2024 (1,819,723 shares), and in the IPO on 02/07/2025 (1,022,586 shares).


Analysis · SION · Life Sciences

A director-affiliated 10% stockholder, RA Capital Healthcare Fund, has filed to sell 3,448,811 shares worth approximately $21.8 million. This is a significant distribution by a major insider, especially against the backdrop of Sionna's recent clinical failure and 46% workforce reduction. The sale represents roughly 7.6% of the company's outstanding shares and comes just three days after the company announced a strategic pivot following the SION-719 Phase 2a failure.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SION was trading at $7.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $324.6M. The 52-week trading range was $4.01 to $54.97. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SION - Latest Insights